Evidence map›Paper›PMID 40468322›Full record

ArticleBreast cancer research : BCR2025

Correction: Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.

Marie-Julie Nokin, Justine Bellier, Florence Durieux, Olivier Peulen, Gilles Rademaker, Maude Gabriel, Christine Monseur, Benoit Charloteaux, Lieven Verbeke, Steven van Laere and 11 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Breast cancer research : BCR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Marie-Julie NokinMetastasis Research Laboratory, GIGA-Cancer, University of Liège (ULiège), Pathology Tour, +4 level, Building 23, Avenue Hippocrate 13, Liège, 4000, Belgium.
Justine BellierMetastasis Research Laboratory, GIGA-Cancer, University of Liège (ULiège), Pathology Tour, +4 level, Building 23, Avenue Hippocrate 13, Liège, 4000, Belgium.
Florence DurieuxMetastasis Research Laboratory, GIGA-Cancer, University of Liège (ULiège), Pathology Tour, +4 level, Building 23, Avenue Hippocrate 13, Liège, 4000, Belgium.
Olivier PeulenMetastasis Research Laboratory, GIGA-Cancer, University of Liège (ULiège), Pathology Tour, +4 level, Building 23, Avenue Hippocrate 13, Liège, 4000, Belgium.
Gilles RademakerMetastasis Research Laboratory, GIGA-Cancer, University of Liège (ULiège), Pathology Tour, +4 level, Building 23, Avenue Hippocrate 13, Liège, 4000, Belgium.
Maude GabrielMetastasis Research Laboratory, GIGA-Cancer, University of Liège (ULiège), Pathology Tour, +4 level, Building 23, Avenue Hippocrate 13, Liège, 4000, Belgium.
Christine MonseurMetastasis Research Laboratory, GIGA-Cancer, University of Liège (ULiège), Pathology Tour, +4 level, Building 23, Avenue Hippocrate 13, Liège, 4000, Belgium.
Benoit CharloteauxGenomics Platform, GIGA, ULiège, Liège, Belgium.
Lieven VerbekeDepartment of Information Technology, Ghent University, Ghent, Belgium.
Steven van LaereTranslational Cancer Research Unit, University of Antwerp, Antwerp, Belgium.
Patrick RoncaratiLaboratory of Experimental Pathology, GIGA-Cancer, ULiège, Liège, Belgium.
Michael HerfsLaboratory of Experimental Pathology, GIGA-Cancer, ULiège, Liège, Belgium.
Charles LambertLaboratory of Connective Tissues Biology, GIGA-Cancer, ULiège, Liège, Belgium.
Jean ScheijenLaboratory for Metabolism and Vascular Medicine, Department of Internal Medicine, Maastricht University, Maastricht, The Netherlands.
Casper SchalkwijkLaboratory for Metabolism and Vascular Medicine, Department of Internal Medicine, Maastricht University, Maastricht, The Netherlands.
Alain ColigeLaboratory of Connective Tissues Biology, GIGA-Cancer, ULiège, Liège, Belgium.
Jo CaersLaboratory of Hematology, GIGA-Inflammation, Infection and Immunity, ULiège, Liège, Belgium.
Philippe DelvenneLaboratory of Experimental Pathology, GIGA-Cancer, ULiège, Liège, Belgium.
Andrei TurtoiInstitut de Recherche en Cancérologie de Montpellier, Inserm U1194, Montpellier, France.
Vincent CastronovoMetastasis Research Laboratory, GIGA-Cancer, University of Liège (ULiège), Pathology Tour, +4 level, Building 23, Avenue Hippocrate 13, Liège, 4000, Belgium.
Akeila BellahcèneMetastasis Research Laboratory, GIGA-Cancer, University of Liège (ULiège), Pathology Tour, +4 level, Building 23, Avenue Hippocrate 13, Liège, 4000, Belgium. a.bellahcene@uliege.be.ORCID https://orcid.org/0000-0001-9154-7631

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40468322
PMCPMC12139075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.